LoginSignup
Danaher logo

Danaher

Stock
Stock
ISIN: US2358511028
Ticker: DHR
US2358511028
DHR

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Danaher has so far distributed $0.27 in 2025. The next dividend will be paid on 26.04.2025

$0.32

CHART BY

Frequently asked questions

What is Danaher's market capitalization?

The market capitalization of Danaher is $160.88B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Danaher's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Danaher is 42.11. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Danaher?

Danaher's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.287. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Danaher's stock?

Currently, 28 analysts cover Danaher's stock, with a consensus target price of $268.29. Analyst ratings provide insights into the stock's expected performance.

What is Danaher's revenue over the trailing twelve months?

Over the trailing twelve months, Danaher reported a revenue of $23.88B.

What is the EBITDA for Danaher?

Danaher's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $7.22B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Danaher?

Danaher has a free cash flow of $5.30B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the free float of Danaher's shares?

The free float of Danaher is 692.83M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$160.88B
EPS (TTM) 
$5.287
Free Float 
692.83M
P/E ratio (TTM) 
42.11
Revenue (TTM) 
$23.88B
EBITDA (TTM) 
$7.22B
Free Cashflow (TTM) 
$5.30B

Pricing

1D span
$222.43$227.34
52W span
$221.43$281.38

Analyst Ratings

The price target is $268.29 and the stock is covered by 28 analysts.

Buy

23

Hold

5

Sell

0

Information

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US2358511028
Primary Ticker
DHR

Knockouts

Join the conversation
Sign upLogin